Inovio Pharmaceuticals

INO

Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020).

Inovio Pharmaceuticals has been a target of short sellers for a while. The current short interest of 18.62% is significantly above the average of the last 12 months (12.07%).